Pages

Showing posts with label Polyphenols. Show all posts
Showing posts with label Polyphenols. Show all posts

Monday, 23 March 2020

Can drinking red wine ever be good for us? - BBC

We’ve been led to believe that an occasional glass of wine might be better than abstaining from alcohol altogether, but that might not be the case.



By Jessica Brown

22nd October 2019


* This story is featured in BBC Future’s “Best of 2019” collection. Discover more of our picks.
Even though alcohol kills millions of people every year, humans have been imbibing for millennia. In the last few decades, wine, in particular, has gained a reputation for being good for our health. Red wine even has been linked with longevity and lower risk of heart disease.
But could wine really be good for us?
The first question, of course, is what we mean by “good for us”. Many people think of heart health when we think of the potential upsides of wine.
What is less well-known is that research has found strong links between alcohol and cancer. One bottle of wine per week is associated with an increased absolute lifetime cancer risk for non-smokers of 1% for men and 1.4% for women. This equates one bottle of wine per week to five cigarettes for men, or 10 for women.
“While a lot of work [has] been done to communicate the link between smoking and cancer, this is less so for alcohol because public health officials control messaging for smoking, whereas with alcohol, it’s largely been up to the alcohol industry to communicate this itself,” says Mark Bellis, director of policy, research and international development at Public Health Wales.
The idea that research shows a tipple can be beneficial dates back to the 1970s, when scientists found that French people were less likely to have heart disease than other populations, despite eating more saturated fat. There was a clear relationship between lower levels of heart disease and wine consumption. This came to be known as the French paradox – a conundrum which scientists are still untangling today.

In the 1970s, scientists found that French people were less likely to have heart disease – which may be related to wine consumption (Credit: Getty Images)
We have since been led to believe that moderate wine-drinking can reduce our risk of heart disease, high blood pressure, diabetes, and weight gain.
“Early research found that moderate levels of wine consumption had a ‘J’-shaped curve effect,” says Helena Conibear, co-director of The International Scientific Forum on Alcohol Research. “Small, regular amounts of wine seem to lead to longer life, better health and less cognitive decline. Since then, more than 1,000 papers have been published reiterating that.”
As a result, for a long time, the consensus was that abstaining from alcohol is unhealthier than consuming moderate amounts of alcohol (equivalent to one or two drinks a day).
But that “J”-shaped relationship between alcohol consumption, and death and disease, has come under criticism. It’s now widely understood that a lot of this data could be flawed: people abstaining from alcohol may be doing so because they’re unwell, rather than becoming unwell because they’re abstaining. (This challenge in sorting out cause from effect is the issue with many observational studies, which most nutrition studies are).
When controlling for this, one 2006 analysis of 54 previously published studies found no correlation between moderate alcohol consumption and lower risk of heart disease.


Studies have found that moderate drinkers have a lower risk of heart disease… but also that they don’t (Credit: Getty Images)
But in the years since, says Conibear, other studies have found the opposite. “Over the last five years, research has looked at confounding factors,” she says. “We know wine drinkers tend to be better off, better educated and have a less sedentary lifestyle – and adjusting for that, the J-shaped curve can’t be denied.”
She says researchers have got around this bias by using participants who’ve never drunk before, rather than those who used to drink and now abstain, as they’re more likely to abstain for health reasons.
In one 2019 study, researchers took a different approach to determine whether moderate alcohol intake really is linked to lower risk of heart disease. For 10 years, they followed more than 500,000 adults in China, where two genetic variants (ALDH2-rs671 and ADH1B-rs1229984) influence alcohol drinking patterns, rather than ill health. They also excluded people with poor health.
“Those with no defects can drink as much as they like,” says Zhengming Chen, one of the study’s authors and professor of Epidemiology, at the University of Oxford’s Nuffield Department of Population Health. “But those with a dysfunctional enzyme can’t tolerate alcohol at all,” he says.
The researchers also used Chinese women as a control group, because while many Chinese women can metabolise alcohol, many don’t drink for social, rather than health reasons, Chen says.


One study found the more people drank, the more likely they were to experience high blood pressure and stroke, but not heart attacks, over a 10-year period (Credit: Getty Images)
This time, the researchers found no “J”-shaped correlation. Instead, they found that the more people drank, the more likely they were to experience high blood pressure and stroke – and there was no reduced risk among people who drank one to two units per day. There was no association either way with heart attacks.
As a result, while there was a clear link between alcohol consumption and stroke risk, something in alcohol may protect us against heart attacks.
“Our study shows that alcohol definitely has a protective mechanism, because high alcohol consumption consistently increases blood pressure, but for heart disease the association is quite flat,” Chen says.

Alcohol in general may offset the heart disease risk of increased blood pressure, but it’s unclear if it’s enough to offset even high blood pressure (Credit: Getty Images)
“So even as blood pressure goes up, there may be another mechanism that offsets increased blood pressure. But we don’t know if this protective mechanism is enough to offset high blood pressure.”
It’s important to note that the researchers converted all alcoholic drinks into standard alcoholic units, so the results aren’t specific to wine. However, Chen argues wine wouldn’t have shown any different results.
Red wine
But wine normally is considered the “healthier” option because of its antioxidants called polyphenols. Also found in fruit and vegetables, polyphenols reduce inflammation in the body, which is a factor for disease. There are ten times as many in red wine than white.
Alberto Bertelli, a researcher at the University of Milan's department of Biomedical Sciences for Health, has found that small amounts of wine can protect us against heart disease, partly due to the drink’s anti-inflammatory properties. He recommends no more than 160ml of wine a day (the size of a champagne flute), but only with a meal, Mediterranean style.
Research has focused on the polyphenol resveratrol in particular, a naturally occurring compound found in grapes’ skin and seeds. Resveratrol is thought to protect against high blood pressure by dilating blood vessels.

Most research on wine and health has focused on resveratrol, an antioxidant found in grapes (Credit: Getty Images)
But despite there being no resveratrol in white wine (even though it’s in white grapes), Bertelli observed the French paradox also applies to white wine-drinking areas in France. In other words, white wine may have the same health benefits – if wine has benefits at all.
“We found in white wine two compounds common to extra virgin olive oil, which is recognised as a healthy food, more or less in the same amount,” Bertelli says. These compounds, tyrosol and hydroxytyrosol, have also been found to be protective against Alzheimer’s disease.
Most researchers, however, have found that the vast majority of any believed health benefits apply only to red wine.
Red wine may be good for gut health, which has numerous benefits to the rest of our body, including improved immunity and digestion, and a healthier weight. In a recent study, researchers studied the drinking habits of twins and found that drinking red wine could improve the diversity of bacteria in the gut, which is linked to better health. But the observed benefits on gut health were found with just one glass of red wine per week, and anyone drinking more than two small glasses a day was excluded from the study. (Find out how your the bugs in your belly could heal your brain.)

A glass of red wine a night is associated with lower BMI and better gut health, but red wine drinkers may simply be healthier to begin with (Credit: Getty Images)

The researchers also found that people who drank red wine had a lower body mass index (BMI). This also could be why drinking red wine in moderation is associated with health. It’s not that red wine makes you healthier; it’s that red wine drinkers may be healthier to begin with.
“People who drink red wine often also do more exercise and [are] more affluent and healthier,” says Bellis.
The same is true of the gut health question: because the study was observational, the researchers couldn’t establish whether a single glass of red wine a week makes your gut healthier, or people with healthier guts happened to be the kind to drink a glass a week. And randomised control trials, where participants are split into groups and their health measured as they follow different diets, can be particularly unethical when it involves alcohol.
There have been a few randomised control trials – but these have been less than conclusive. A 2016 study found that having one glass of red wine with their evening meal every day for six months didn’t affect the blood pressure of people with diabetes.
Another randomised control study from 2015 found that drinking 150ml of red wine (again, the amount held in a champagne flute), can lower the risk of developing stroke and heart disease among people with diabetes.
Healthiest option
In fact, while red wine may be the healthiest drink option, it’s healthier to abstain entirely, says author of the study looking at wine consumption and gut health, Caroline Le Roy, research associate at the Department of Twins Research at Kings College London.

“We know alcohol is bad for us,” she says. “If you drink, it should be red wine, as this is the only alcoholic drink that’s been found to have a beneficial effect, but I’m not encouraging people to drink red wine.”

Red wine is the only alcoholic drink that’s been found to have any health benefit – but that still doesn’t mean it’s a healthy option (Credit: Getty Images)
Research generally attributes any protective mechanism to resveratrol. But while some researchers believe resveratrol’s ability to be absorbed into the bloodstream is enough to derive antioxidant effects, others doubt it stays in the bloodstream for long enough to benefit us.
“There’s controversy around the level of dose you can absorb from a glass of wine, and its bioavailability, which is the body’s ability to absorb it and do us good,” says Conibear.
There has been increasing attention on resveratrol supplements in recent years. However, data on the effectiveness of resveratrol pills is conflicting. Bertelli argues that we need the alcohol component of wine to absorb resveratrol.
“Resveratrol has the same bioavailability as other polyphenols in fruit, but it doesn’t matter how much you ingest, it matters how much gets into the bloodstream,” he says.
“Before we absorb the compounds in wine, they must be dissolved. They help others absorb, they all work together, and this is unique to wine,” he says.
According to UK guidelines, which are among the most stringent globally, we should drink  no more than 14 units of alcohol per week. While the research on any health benefits of wine is nascent, it is still largely agreed that the healthiest option is to abstain – and that red wine is the healthiest option for those who do drink.

But we shouldn’t drink red wine for any health benefits, Bellis says, because there are numerous ways to boost our health more effectively. “Of course people want to hear that the half a bottle of wine they drink after work is at least doing them no harm, and even better, could be doing them some good. But that’s far from truth,” he says.
Want to boost your health? Eating more fruits and vegetables, and exercising, remain the best and most proven ways to do it – not pouring yourself a glass of wine.

Thursday, 9 January 2020

UN-TEA-LIEVABLE Drinking three cups of tea a week can help you live longer, study finds

DRINKING at least three cups of tea a week is linked to a longer, healthier life, scientists say.

Their study found green tea was the best but all those enjoying a regular cuppa benefit too.
 Researchers found drinking three cups of tea a week could be linked to a longer life
1
Researchers found drinking three cups of tea a week could be linked to a longer lifeCredit: Getty - Contributor
It is believed polyphenols in the brew protect against heart disease and raised blood pressure.
The researchers estimated 50-year-old regular tea drinkers had a 20 per cent lower risk of heart disease and stroke, and a 22 per cent lower risk of dying from either.
Their danger of death from any cause was also found to drop 15 per cent.
Brit favourite black tea was drunk by only eight per cent in the South East Asian study so the benefits were unclear.
The Chinese team suggests green tea is rich in polyphenols but black tea is fully fermented so may lose some of their effects.
In addition, black tea is often served with milk, which may counteract the favourable health effects.
Lead study author Dr Xinyan Wang, from the Chinese Academy of Medical Sciences in Beijing, said:
"Habitual tea consumption is associated with lower risks of cardiovascular disease and all-cause death.
"The favourable health effects are the most robust for green tea and for long-term habitual tea drinkers."
https://www.thesun.co.uk/news/10702634/drinking-tea-boosts-life-expectancy/

Wednesday, 27 November 2019

Five Healthy Benefits of Drinking Black Tea

It’s one of the most popular drinks in the world. About 80% of tea drinkers choose black tea.1 It’s rich in antioxidants, nutrients, and amino acids. The result? A drink with major health benefits…from strengthening bones to preventing heart disease.

INH Research


Here are five healthy benefits of drinking black tea:
1. Strengthens Bones: Studies show that black tea helps improve bone density. One study revealed higher bone density in daily drinkers than people who didn’t drink it.2 It’s the polyphenols that deliver this benefit.
Black tea can also help save your teeth. The antioxidants in it can kill bacteria. The kind that cause gum disease and tooth decay. Researchers found that three cups of it a day can fight off Streptococcus mutans and Lactobacillus. Even people who took tooth-rotting sugar in their tea saw some protective benefit… But we recommend you skip it completely.3
2. Improves Heart Health: Drinking a daily serving of black tea can reduce your stroke risks by up to 21%.4 One study found it helped lower total triglyceride levels by about 36% in three months.5 This is because it’s rich in theaflavins and thearubigins. You won’t find these compounds in green tea.
This same study also found over a 400% increase in the antioxidant concentration of subjects’ blood. More antioxidant power means less inflammation and oxidative stress. But there’s another benefit researchers found in this study…
3. Balances Blood Sugar: Researchers also revealed that black tea can decrease blood sugar levels by nearly 20%. It’s not surprising that other studies link black tea to a reduction in diabetes risk.6 One of them found that drinking this tea may help lower type 2 diabetes risk by as much as 70%.7 Another study revealed that four daily cups of black tea can reduce inflammation and oxidation in type 2 diabetics.8
4. Prevents Lung Damage: A team of researchers in India compared the lung-protective benefits of black tea in guinea pigs. After a week of testing, they found animals that drank water developed lung damage when exposed to cigarette smoke. But not the black tea group.
The guinea pigs that drank black tea didn’t experience oxidative stress or inflammation when they were exposed. This doesn’t mean drinking a ton of black tea can reverse the lung damage smoking causes… But it does suggest protection from secondhand smoke and toxin exposure.9
5. Reduces Cell Death: When important cells start to deteriorate and die in your body, it means serious trouble. Conditions like Alzheimer’s, Parkinson’s, and Lou Gehrig’s disease. But black tea can help prevent neurodegenerative diseases…
A study from China found drinking it helped to lower risk of developing Parkinson’s disease. Researchers observed that subjects who drank the most saw a 29% reduction in risk. Yet green tea didn’t have this effect. This means black tea’s compounds may be unique when it comes to protecting your brain.10
To get the most health benefits from black tea, drink it in its natural, organic state. Don’t buy the sweetened or flavored varieties. And don’t steep it for too long. This may minimize the health benefits. You can find quality black tea in most health stores and online.
References:
1http://www.teausa.com/14655/tea-fact-sheet
2http://www.telegraph.co.uk/health/3356550/Healthy-drinking-Tea-total.html
3http://www.dailymail.co.uk/health/article-2401287/Teas-dental-benefits-Black-tea-combats-bacteria-linked-tooth-decay-gum-disease.html
4http://www.ncbi.nlm.nih.gov/pubmed/19228856
5http://www.sciencedirect.com/science/article/pii/S0091743511004877
6http://www.berkeleywellness.com/healthy-eating/food/article/tea-benefits-research-wrap
7http://www.ncbi.nlm.nih.gov/pubmed/19259345
8http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055352/
9http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1802835/
10http://aje.oxfordjournals.org/content/167/5/553.full

https://www.institutefornaturalhealing.com/2014/12/five-healthy-benefits-of-drinking-black-tea/

Wednesday, 30 October 2019

Aspirins - Platelet clumping, Heart attacks and Strokes - by Life Extension

Why Many People May Not Need Aspirin Today - One of aspirin’s beneficial effects is to prevent blood platelets from clumping and blocking blood flow,5,6 including inside a coronary or cerebral artery...
LIFE EXTENSION MAGAZINE
August 2019
By William Faloon
Starting in the 1970s, a number of published studies found that people who regularly took aspirin had reduced risk of heart attack and other vascular disorders.1-4
As evidence mounted, the FDA approved low-dose aspirin in 1998 to treat high-risk patients, including those who had already suffered a heart attack or ischemic stroke.
Tacit approval to take low-dose aspirin daily was also given for healthy adults concerned about occlusive vascular disorders.
One of aspirin’s beneficial effects is to prevent blood platelets from clumping and blocking blood flow,5,6 including inside a coronary or cerebral artery.
Back in the early years when aspirin demonstrated efficacy, the typical Americans’ behavior patterns put them at high risk for abnormal platelet clumping, which in turn caused soaring numbers of heart attacks and strokes.7
In the period of 1980 to 2014, however, death rates from cardiovascular disease incrementally plummeted by 50%.8
This improvement coincides with better control of blood pressure and lipids, and a decrease in smoking tobacco,5,6 along with changing dietary practices and improved cardiovascular procedures and interventions.
Overlooked by the mainstream is an almost 20-fold increase in the use of dietary supplements, many of which have many similar effects as aspirin in protecting the cardiovascular system.9
Recent studies are finding that aspirin is not reducing heart attack/stroke risk in today’s healthier American population compared to earlier decades.5,6 Aspirin is still proving effective in certain high-risk groups, as will be described in this editorial.5,10
So the debate swirling in medical settings is whether otherwise healthy Americans should continue taking low-dose aspirin.
Our analysis reveals that adults at low risk of cardiovascular disease who control their risk factors, including protecting against abnormal platelet clumping, may not need daily low-dose aspirin. This editorial describes our rationale.
If we travel back to the 1950s-1970s era, a typical American man or woman might, after waking up, eat a breakfast consisting of bacon, eggs, and buttered toast, with sugar and/or cream-laden coffee. Many would also light up a cigarette.
The morning hours are when blood platelets are most “sticky.”
Mornings are also when most sudden heart attacks were occurring in those decades.11
Consumption of polyphenol-rich fruits, vegetables, and dietary supplements in this 1950s-1970s period was low.
Systolic blood pressure over 150mmHg was quite normal, and many people had high cholesterol levels,12,13 sometimes exceeding 300 mg/dL.
Add together the above five paragraphs and you may see why sudden-death heart attacks surged to epidemic levels during the 1950s-1970s period.
Typical breakfast foods consumed in that time period increased abnormal platelet aggregation (clumping), smoking caused more platelet clumping, and few anti-platelet-clumping foods or nutrients were consumed.
So, when studies published in the prior decades identified regular aspirin users as having reduced heart attack rates, there was a biological explanation for this, since aspirin markedly lowered the platelet clumping that was encouraged by typical lifestyles during this era.
 
Man clutching his heart
“In 1965, 45% of Americans smoked, today it’s only 15%… That’s the lowest percentage ever recorded.”*
*Smithsonian.com based on Centers for Disease Control and Prevention 2015 report.19

American Heart Association Update March 18, 2019

Earlier this year, the American Heart Association published an article that corresponds to much of what we state as it relates to changing American health behavior patterns. Here is an excerpt from the news report:
“Heart attack rates have gone down in more modern society with lower smoking rates and better treatment of blood pressure, better treatment of cholesterol… There probably was more of a role for aspirin back in the older trials, even though the bleeding issue has always been seen there.”36
The reasons cited by the American Heart Association, and many more provided in this editorial, indicate why otherwise healthy American adults may no longer need low-dose aspirin for primary heart attack prevention.

What Has Changed Today?

blood preassure
Even a cursory look at health behavior patterns in the 1950s-1970s compared to recent years reveals startling changes.
There have been huge reductions in average blood pressure readings and lipid numbers.12,14,15 These two factors alone dramatically reduce platelet clumping (thrombotic) risks.16,17
Dietary practices among health conscious individuals reduce or eliminate breakfast foods like bacon, ham, and fried eggs that contribute to platelet aggregation.
Specifically, health-conscious individuals have become aware that ingestion of saturated fats (and certain other fats like trans-fats) is a culprit behind platelet aggregation and subsequent coronary heart attacks and ischemic strokes.
Tobacco usage has plummeted18 while intake of nutrients that protect against platelet aggregation has soared.
Stated succinctly, there is no comparison between the vascular health status of the typical American in the 1950s-1970s and the same indices in more recent decades.
Plummeting incidences of heart attacks and strokes caused by abnormal platelet aggregation attest to this.
So, while aspirin saved many lives in the past, it may not have this same effect today. That’s because there is far less abnormal platelet clumping and thus less coronary or cerebral artery blockage (occlusion) happening.5,6
CURRENT CONVENTIONAL “PRIMARY PREVENTION” GUIDELINES FOR DAILY LOW-DOSE ASPIRIN
Primary prevention in cardiovascular disease is defined as reducing the risk of having an initial cardiovascular event, like a heart attack (myocardial infarct) or stroke (cerebrovascular accident).
In comparison, secondary prevention is defined as reducing the risk of having a second, or subsequent, cardiovascular event.
Low-dose (75-100 mg daily) aspirin use for secondary prevention is well established.35
However, based upon several new, high-quality clinical studies (randomized, placebo-controlled, direct intervention trials), the use of aspirin for
generalized primary prevention has been revised.28-32
These revisions reflect the differences between patient populations today in comparison with the past5,6 – for example, patients today achieve better blood pressure control, have better cholesterol profiles, and use less tobacco than “comparable” patients in the past, especially 30-plus years ago.
According to the 2019 Guidelines for Primary Prevention of Cardiovascular Disease from the American College of Cardiology (ACC) and the American Heart Association (AHA), current recommendations on the use of aspirin for primary prevention stipulate:5
  • Low-dose aspirin (75-100 mg orally daily) may be considered for primary prevention of cardiovascular disease in high-risk adults (e.g., patients at high risk of a cardiovascular event, like type II diabetes patients as well as those patients with multiple cardiovascular risk factors such as poor blood pressure control, active tobacco use, and elevated LDL cholesterol) aged 40-70 years, not at increased bleeding risk;
  • Low-dose aspirin should not be administered on a routine, generalized basis for primary prevention of cardiovascular disease among otherwise healthy adults >70 years, not at high cardiovascular risk;
  • Low-dose aspirin should not be administered for primary prevention among adults at any age who are at increased bleeding risk.

Nutrients That Impede Platelet Aggregation

Thrombosis is the leading cause of death in persons over age 50.20
The major cause of thrombosis is abnormal platelet aggregation (clumping) inside arteries and veins.

It is critical that aging persons follow anti-thrombotic practices that include ingesting nutrients that help prevent blood platelets from sticking together.
I believe every reader of Life Extension Magazine® is already taking many of these anti-platelet nutrients. They include plant polyphenols like curcumin, green tea, pine bark, and pomegranate, optimized forms of folate, vitamins B6 and B12, along with omega-3 fatty acids.21-27

These nutrients have differing anti-platelet properties. This is important because there are several mechanisms that cause abnormal platelet aggregation.
Compare what health-conscious Americans have done in recent decades to reduce their thrombotic heart attack and stroke risks to the 1950s-1970s period. The difference is night and day.
It helps explain why recent studies seeking to demonstrate the effect of aspirin on heart attack prevention in healthy people have largely failed to do so.28-32
Today’s radically altered health behavior patterns drastically reduce platelet stickiness. Further reducing platelet aggregation with aspirin may not add additional benefit to healthy people, as recent studies indicate.5,6
REDUCED SECONDHAND SMOKE EXPOSURE SLASHES THROMBOTIC CARDIOVASCULAR RISKS
Most of you may recall being chronically exposed to other people’s cigarette smoke in the workplace, around recreation areas, while traveling, and at home.
Here is what the Surgeon General and the Institute of Medicine write about the cardiovascular dangers of secondhand smoke:37-42
  • Exposure to secondhand smoke has immediate adverse effects on the cardiovascular system and can cause coronary heart disease and stroke.
  • Secondhand smoke causes nearly 34,000 premature deaths from heart disease each year in the United States among nonsmokers.
  • Nonsmokers who are exposed to secondhand smoke at home or at work increase their risk of developing heart disease by 25%–30%.
  • Secondhand smoke increases the risk for stroke by 20%− 30%.
  • Secondhand smoke exposure causes more than 8,000 deaths from stroke annually.
  • Breathing secondhand smoke can have immediate adverse effects on your blood and blood vessels, increasing the risk of having a heart attack.
  • Breathing secondhand smoke interferes with the normal functioning of the heart, blood, and vascular systems in ways that increase the risk of having a heart attack.
  • Even brief exposure to secondhand smoke can damage the lining of blood vessels and cause your blood platelets to become stickier. These changes can cause a deadly heart attack.
Over the past 25 years, public health initiatives have resulted in huge reductions in secondhand smoke exposure, which further lowers thrombotic heart attack and ischemic stroke risk.
These data help further explain why studies in early years showed reduced heart attack risk in aspirin users.
In today’s relatively secondhand-smoke-free world, the potent anti-thrombotic effects of daily aspirin are not always going to show reduced heart attack risk because this major environmental threat has been largely eliminated.

Blood Pressure and Platelet Aggregation

With each heartbeat, blood is pushed through your arteries into microscopic capillaries and then out through veins for return to your heart.
Elevated systolic blood pressure increases mechanical stress that compromises the integrity of the inner arterial wall called the endothelium. This can lead to a pro-inflammatory and pro-thrombotic state that is an underlying cause of heart attack or ischemic stroke.
Blood pressure guidelines in earlier years allowed levels that were too high. Back in those days medications to treat hypertension were not particularly effective compared to more recent decades.33
When aspirin was showing significant efficacy in reducing heart attack risk, people with high blood pressure, including prehypertension­, were not adequately controlling it with diet, lifestyle, and medication.
This same problem persists today among people who are not proactive in protecting against vascular disease.
Average blood pressure readings have been dropping in recent decades in most population groups, though the growing number of overweight/obese individuals is counteracting this favorable trend.
Those who achieve better blood pressure control enjoy reduced platelet aggregation.34
These individuals are therefore less likely to benefit from daily aspirin use compared to past generations that lived with elevated blood pressure.

Lipids and Blood Pressure

Foods and nutrients with anti-platelet properties
In the early 1980s, the standard reference ranges for LDL cholesterol and triglycerides were too high. These antiquated reference ranges put many people at risk for coronary artery occlusion and subsequent heart attack (myocardial infarction) in earlier decades.
Elevated lipids accelerate atherosclerotic processes. This increases the risk of platelets aggregating around unstable arterial plaque and causing coronary and cerebral artery blockages.
Huge declines in average lipid levels beginning in the late 1980s provide further rationale for why aspirin is not demonstrating similar beneficial effects in more recent studies.5,6,12,15
Back in the previous period (1950s-1970s) little was done in the conventional setting to prevent atherosclerosis, be it diet, exercise, supplements or drugs.
These facts cannot be overstated. When Americans were suffering epidemic levels of heart attacks, laboratory reference ranges for blood lipids were frighteningly high.
This predisposed a large swath of Americans to abnormal platelet aggregation that aspirin helped protect against.
Many of today’s health-conscious people may no longer need this additional anti-platelet protection, as their blood pressure and blood lipids are markedly lower.

Who Should Take Aspirin?

The term “primary prevention” applies to the use of low-dose aspirin in seemingly healthy individuals who have elevated risk factors for coronary heart attack and ischemic stroke.
The box on the next page describes patient groups who should be taking low-dose aspirin for primary prevention, i.e. before they suffer a thrombotic heart attack or stroke.
The term “secondary prevention” applies to people who already suffer angina and/or severe coronary blockage, or are survivors of a heart attack, transient ischemia attack, ischemic stroke or other occlusive arterial disease.
For this group of individuals with preexisting vascular disease, aspirin is clearly established for secondary prevention, i.e. preventing another cardiovascular event.10,35
The debate going on now is what to recommend to normal, aging people with borderline vascular risks.
Alternative practitioners have long claimed the anti-platelet effects of healthy diets, exercise, and nutrient extracts that exhibit aspirin-like properties are more than sufficient.
The bottom line is that there are no clear-cut answers for otherwise healthy, aging people.

What Should You Do?

For many readers of this magazine, daily low-dose aspirin may be a reasonable option, but there is no real “typical” reader of this magazine.
I’m sometimes surprised that those who support our healthy longevity projects do not always optimize their own cardiovascular health.
What’s important to understand is that there are several mechanisms by which an abnormal clot can form inside a blood vessel.
By consuming a healthy diet, taking a spectrum of anti-platelet nutrients, and avoiding other platelet clumping factors, thrombotic risks are likely to be significantly reduced, and the published medical literature supports this.
For longer life,
For Longer Life
William Faloon, Co-Founder
Life Extension Buyers Club
P.S. For an in-depth review of different approaches to reduce a hypercoagulability condition and/or abnormal platelet aggregation please visit our blood-clot prevention protocol at: LifeExtension.com/thrombosis

References

  1. Elwood PC, Cochrane AL, Burr ML, et al. A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J. 1974 Mar 9;1(5905):436-40.
  2. Aspirin in coronary heart disease. The Coronary Drug Project Research Group. J Chronic Dis. 1976 Oct;29(10):625-42.
  3. Linos A, Worthington JW, O’Fallon W, et al. Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. A long-term follow-up study. Mayo Clin Proc. 1978 Sep;53(9):581-6.
  4. Breddin K, Loew D, Lechner K, et al. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study. Thromb Haemost. 1979 Feb 28;41(1):225-36.
  5. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019 Mar 17:CIR0000000000000678.
  6. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005 Mar 31;352(13):1293-304.
  7. Haft JI. Role of blood platelets in coronary artery disease. Am J Cardiol. 1979 Jun;43(6):1197-206.
  8. Roth GA, Dwyer-Lindgren L, Bertozzi-Villa A, et al. Trends and Patterns of Geographic Variation in Cardiovascular Mortality Among US Counties, 1980-2014. JAMA. 2017 May 16;317(19):1976-92.
  9. Available at: https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-agencys-new-efforts-strengthen-regulation-dietary. Accessed May 31, 2019.
  10. Smith SC, Jr., Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011 Nov 29;124(22):2458-73.
  11. Schwartz BG, Mayeda GS, Burstein S, et al. When and why do heart attacks occur? Cardiovascular triggers and their potential role. Hosp Pract (1995). 2010;38(3):144-52.
  12. Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005 Oct 12;294(14):1773-81.
  13. Moser M. Historical perspectives on the management of hypertension. J Clin Hypertens (Greenwich). 2006 Aug;8(8 Suppl 2):15-20; quiz 39.
  14. Collaboration NCDRF. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017 Jan 7;389(10064):37-55.
  15. Hopstock LA, Bonaa KH, Eggen AE, et al. Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905-1977 in the population-based Tromso Study 1979-2016. BMJ Open. 2017 Aug 21;7(8):e015001.
  16. Blann AD, Nadar S, Lip GY. Pharmacological modulation of platelet function in hypertension. Hypertension. 2003 Jul;42(1):1-7.
  17. Sikora J, Kostka B, Marczyk I, et al. Effect of statins on platelet function in patients with hyperlipidemia. Arch Med Sci. 2013 Aug 30;9(4):622-8.
  18. CDC. Centers for Disease Control and Prevention. Achievements in Public Health, 1900-1999: Tobacco Use — United States, 1900-1999. MMWR. 1999;48(43):986-93.
  19. Available at: https://www.smithsonianmag.com/smart-news/only-15-percent-americans-smoke-180956504/. Accessed June 10, 2019.
  20. Becker Richard C. MD. Textbook of Coronary Thrombosis and Thrombolysis.
https://www.lifeextension.com/magazine/2019/8/as-we-see-it/page-01